Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 18.1 CNY -4.99% Market Closed
Market Cap: 20.2B CNY
Have any thoughts about
Shenzhen Kangtai Biological Products Co Ltd?
Write Note

Relative Value

The Relative Value of one Shenzhen Kangtai Biological Products Co Ltd stock under the Base Case scenario is 34.5 CNY. Compared to the current market price of 18.1 CNY, Shenzhen Kangtai Biological Products Co Ltd is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
34.5 CNY
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
61
Median 3Y
10.1
Median 5Y
13.2
Industry
7.7
Forward
5.8
vs History
61
vs Industry
7
Median 3Y
39.5
Median 5Y
57.5
Industry
22.7
Forward
37.2
vs History
76
vs Industry
8
Median 3Y
34.5
Median 5Y
46.1
Industry
21.6
vs History
vs Industry
3
Median 3Y
24.5
Median 5Y
-27.7
Industry
25.2
vs History
88
vs Industry
46
Median 3Y
3.7
Median 5Y
5.4
Industry
2.5
vs History
87
vs Industry
51
Median 3Y
10.3
Median 5Y
13.3
Industry
7.7
Forward
6.2
vs History
87
vs Industry
47
Median 3Y
13.1
Median 5Y
16.3
Industry
9
vs History
66
vs Industry
5
Median 3Y
40.5
Median 5Y
58.7
Industry
4.2
Forward
21.2
vs History
66
vs Industry
5
Median 3Y
40.5
Median 5Y
58.7
Industry
4.1
Forward
25.8
vs History
76
vs Industry
7
Median 3Y
34.1
Median 5Y
48
Industry
5.7
vs History
28
vs Industry
1
Median 3Y
-48.3
Median 5Y
-46.6
Industry
3.6
vs History
90
vs Industry
52
Median 3Y
2.9
Median 5Y
4.7
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Shenzhen Kangtai Biological Products Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
20.2B CNY 6.9 39.2 40.2 40.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.6 -76.2
P/E Multiple
Earnings Growth
CN
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Average P/E: 180.1
39.2
-1%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Average EV/EBITDA: 20.5
40.2
52%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.6 N/A
EV/EBIT Multiple
EBIT Growth
CN
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Average EV/EBIT: 25
40.2
47%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top